Effects of Shenkang Pills on Early-Stage Diabetic Nephropathy in db/db Mice via Inhibiting AURKB/RacGAP1/RhoA Signaling Pathway

• Autori principali: Fujing Wang (Autore), Jia'er Fan (Autore), Tingting Pei (Autore), Zhuo'en He (Autore), Jiaxing Zhang (Autore), Liliang Ju (Autore), Zhongxiao Han (Autore), Mingqing Wang (Autore), Wei Xiao (Autore)
• Natura: Libro
• Pubblicazione: Frontiers Media S.A., 2022-02-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Diabetic nephropathy (DN) is the leading cause of end-stage renal disease, so there is an urgent need to suppress its development at early stage. Shenkang pills (SKP) are a hospital prescription selected and optimized from effective traditional Chinese medicinal formulas for clinical treatment of DN...